su011248
Showing 1 - 17 of 17
Urothelial Cancer, Bladder Cancer, Adult Trial in Canada (SU011248, Placebo)
Completed
- Urothelial Cancer
- +2 more
- SU011248
- Placebo
-
Calgary, Alberta, Canada
- +4 more
Aug 20, 2018
Colorectal Carcinoma Trial in Boston (SU011248, Irinotecan, Cetuximab)
Terminated
- Colorectal Carcinoma
- SU011248
- +2 more
-
Boston, Massachusetts
- +2 more
Feb 16, 2017
Metastatic Renal Cell Carcinoma Trial in Riyadh (SU011248)
Completed
- Metastatic Renal Cell Carcinoma
- SU011248
-
Riyadh, Saudi ArabiaKFSH&RC
Jan 4, 2016
Hepatocellular Carcinoma, Liver Cancer Trial in Boston (SU011248)
Completed
- Hepatocellular Carcinoma
- Liver Cancer
- SU011248
-
Boston, Massachusetts
- +2 more
Mar 16, 2014
Prostate Cancer Trial in Los Angeles (SU011248)
Completed
- Prostate Cancer
- SU011248
-
Los Angeles, CaliforniaUniversity of California, Los Angeles, Jonsson Comprehensive Can
Jul 27, 2012
Von Hippel-Lindau Syndrome, Renal Cell Carcinoma, Hemangioblastoma Trial in Houston (SU011248)
Terminated
- Von Hippel-Lindau Syndrome
- +2 more
- SU011248
-
Houston, TexasUT MD Anderson Cancer Center
Feb 23, 2012
Breast Tumors Trial in Worldwide (SU011248, Chemotherapy)
Gastrointestinal Stromal Tumors Trial in France, Italy, United States (SU011248)
Completed
- Gastrointestinal Stromal Tumors
- SU011248
-
Boston, Massachusetts
- +3 more
Sep 9, 2009
Carcinoma, Renal Cell Trial in Worldwide (Interferon-alfa, SU011248)
Gastrointestinal Stromal Tumor Trial in Worldwide (Placebo, SU011248)
Completed
- Gastrointestinal Stromal Tumor
- Placebo
- SU011248
-
Duarte, California
- +60 more
Aug 31, 2009
Breast Tumors Trial in United States (SU011248)
Completed
- Breast Neoplasms
- SU011248
-
Greenbrae, California
- +9 more
Nov 24, 2008
Colorectal Tumors Trial (SU011248)
Completed
- Colorectal Neoplasms
- SU011248
- (no location specified)
Jan 9, 2007